Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Fmoc-D-2-Bromophenylalanine

    • Product Name Fmoc-D-2-Bromophenylalanine
    • Alias Fmoc-D-2-Br-Phe
    • Einecs 841-813-6
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    957125

    Product Name Fmoc-D-2-Bromophenylalanine
    Synonym Fmoc-D-2-Br-Phe-OH
    Chemical Formula C24H18BrNO4
    Cas Number 130873-17-7
    Purity ≥98%
    Appearance white to off-white powder
    Protection Group Fmoc (9-fluorenylmethyloxycarbonyl)
    Chirality D-isomer
    Storage Temperature 2-8°C
    Solubility soluble in DMSO, DMF
    Usage peptide synthesis
    Functional Group bromine, phenyl

    As an accredited Fmoc-D-2-Bromophenylalanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing White, opaque plastic bottle containing 5 grams of Fmoc-D-2-Bromophenylalanine. Clearly labeled with product name, quantity, and safety information.
    Shipping Fmoc-D-2-Bromophenylalanine is shipped in secure, airtight containers to prevent moisture and contamination. The chemical is packed in compliance with international and local regulations for safe transport of research-grade chemicals, often under controlled temperatures. Proper labeling and documentation ensure traceability and safe handling during transit.
    Storage Fmoc-D-2-Bromophenylalanine should be stored in a tightly sealed container, protected from light and moisture, in a cool, dry place (typically 2–8 °C). Avoid exposure to air and heat to prevent degradation. Ensure proper labeling, and store away from incompatible substances such as strong oxidizing agents. Use appropriate personal protective equipment when handling and follow institutional chemical storage guidelines.
    Application of Fmoc-D-2-Bromophenylalanine

    Applications of Fmoc-D-2-Bromophenylalanine in Industrial Manufacturing

    Fmoc-D-2-Bromophenylalanine finds application as a high-purity building block in advanced chemical synthesis, with adoption across several specialized industrial domains where controlled stereochemistry and halogen-functional moieties are critical for downstream product performance and regulatory conformity. Below, we outline the primary industrial segments utilizing this material, specifying real-world use cases, compliance norms, process details, and product categories.

    1. Peptide Active Pharmaceutical Ingredient (API) Manufacturing

    Leading pharmaceutical companies incorporate this amino acid derivative as a non-canonical residue during automated solid-phase peptide synthesis (SPPS) to confer structural diversity and modulate biophysical properties of investigational APIs, particularly in next-generation peptide therapies targeting specific protein interactions.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • European Pharmacopoeia monographs (Ph. Eur.) for amino acid derivatives
    • US FDA 21 CFR Part 211 (Current Good Manufacturing Practice for Finished Pharmaceuticals)
    • ICH Q3A/B (Impurities Guidelines)

    Typical usage ratio

    • 0.5–15 mol% per total amino acid residues, exact proportion based on desired sequence and functionality of the final peptide chain

    Downstream process integration

    • Dissolved in DMF and loaded onto resin during the elongation phase of SPPS; subjected to repeated couplings, deprotection, and cleavage before final purification by preparative HPLC

    Final product types

    • Investigational new drug (IND) peptides
    • Peptide-based hormone analogs
    • Peptidomimetic inhibitors and diagnostics peptides

    2. Custom Peptide Reagent Synthesis for Biotech Research

    Major peptide CROs and life science tool manufacturers use this material in the construction of custom-modified peptides that serve as research tools, enzyme substrates, and interaction probes, where halogen substituents at the phenylalanine position enable site-specific labeling or crosslinking studies.

    Industry compliance standards

    • ISO 9001:2015 (Quality Management Systems for Analytical Reagents)
    • REACH (EC) No 1907/2006 compliance for laboratory chemicals
    • USP General Chapters <1049> for Analytical Reagents

    Typical usage ratio

    • 1–25 mol% of total sequence length, selected based on labeling site density and intended probe activity

    Downstream process integration

    • Built into peptide structure at user-defined positions using commercial SPPS synthesizers, with selective Fmoc deprotection and downstream off-resin modifications for labeling or conjugation

    Final product types

    • Fluorophore-labeled peptide probes
    • Biotinylated capture peptides
    • Photoaffinity crosslinking agents for protein interaction mapping

    3. Discovery and Manufacturing of Stapled Peptides

    Contract development and manufacturing organizations (CDMOs) active in the peptide therapeutics sector deploy this halogenated amino acid as a key handle for crosslink-driven macrocyclization chemistries (“peptide stapling”), introducing conformational constraints that enhance resistance to proteolysis and improve candidate drug selectivity profiles.

    Industry compliance standards

    • ICH Q11 (Development and Manufacture of Drug Substances)
    • US FDA Guidance for Peptide Drug Production
    • EMA Guideline on the Quality of Peptide APIs

    Typical usage ratio

    • 5–10 mol% of total amino acid content, incorporated at one or two specific sites in the peptide chain predetermined by molecular modeling

    Downstream process integration

    • Inserted by SPPS at engineered macrocyclization points; subsequent reaction with alkylating, olefin metathesis, or palladium-catalyzed reagents for stapling, followed by purification

    Final product types

    • Preclinical stapled peptide drug candidates
    • Cyclic peptide-based PPI (protein-protein interaction) inhibitors
    • Stabilized peptide antagonists for oncology pipelines

    4. Synthesis of Peptide-based Structural Biology Tools

    Structural biology and crystallography centers incorporate this compound as a bromine-labeled residue for facilitating phase determination via anomalous X-ray scattering, as well as providing unique electron density signatures for the mapping of peptide-protein complexes at atomic resolution.

    Industry compliance standards

    • ISO 13485:2016 (Quality Management for Laboratory and Research Reagents)
    • World Health Organization Laboratory Biosafety Manual, 4th Edition

    Typical usage ratio

    • 1–3 residue positions per peptide, determined by modeling to maximize anomalous signal strength without altering peptide function

    Downstream process integration

    • Fmoc protection enables precise insertion during SPPS, with the product purified and subsequently co-crystallized or delivered for NMR/X-ray study workflows

    Final product types

    • Brominated peptide crystallization aids
    • Peptide ligands for protein structural studies
    • Peptide-based inhibitors for binding conformation analysis

    5. Building Block for Peptidic Compound Libraries in Drug Screening

    Screening divisions of pharmaceutical and agrochemical companies select this functional amino acid to diversify compound libraries, using its brominated aromatic ring to expand the chemical space sampled during high-throughput screening for new active compounds in disease or crop protection research.

    Industry compliance standards

    • GLP (Good Laboratory Practice) OECD Principles
    • ISO 17025 (Testing and Calibration Laboratories)

    Typical usage ratio

    • 2–20 mol% across diverse peptide sequences, dosage tuned for comprehensive SAR (structure-activity relationship) panel construction

    Downstream process integration

    • Integrated in automated library synthesis arrays using peptide synthesizers; custom loading on resin, parallel SPPS, pooled purification, and subsequent primary or secondary biological screening

    Final product types

    • Peptidic screening libraries
    • Hit identification compounds for lead optimization
    • Precursor pools for focused medicinal chemistry
    Free Quote

    Competitive Fmoc-D-2-Bromophenylalanine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Fmoc-D-2-Bromophenylalanine: Consistency and Reliability from the Manufacturer’s Bench

    Understanding Fmoc-D-2-Bromophenylalanine from the Source

    Producers who spend years refining peptide synthesis know well the importance of every single protected amino acid that goes into a sequence. Fmoc-D-2-Bromophenylalanine stands out in our line, not just as another building block but for what it brings to a lab bench striving for accuracy and creative control. Unlike simpler amino acid derivatives, this one turns up as a backbone for unusual peptide architectures and often makes its way into research both routine and ambitious. Every batch coming out of our reactors reflects our approach to downstream ease and reliability because we've measured and adjusted each step before shipping.

    What Makes Our Fmoc-D-2-Bromophenylalanine Different

    You have ample choices for Fmoc-protected amino acids. Yet, actual users see differences early on. The brominated aromatic ring on our D-2-bromophenylalanine isn’t there for ornamentation. Chemists value it for introducing halogen atoms that facilitate post-synthetic modifications, especially for cross-coupling applications. Synthetic flexibility increases for peptide engineers aiming for bioconjugation or introduction of specialty tags. We've learned from years making this product that trace isomers, racemization, and incomplete deprotection can all trigger downstream troubleshooting. Our team tackles these at the synthesis and purification stages – not by putting a generic guarantee on a label, but by knowing which steps sabotage integrity and removing the guesswork that costs researchers time.

    Technical Details without the Mystery

    Peptide chemists expect more than a catalog page; they want solid data behind every gram. We achieve high levels of optical and chemical purity. Analytical characterization in our labs uses both HPLC and mass spectrometry for each lot so users can build peptides with confidence. The Fmoc protecting group remains stable under typical Fmoc-SPPS protocols, and our product arrives dry enough for straightforward weighing, with particle sizes tailored through controlled grinding so that static and clumping—common headaches during loading—don’t slow the assembly line. Years of manufacturing have shown us how crucial these small details become in high-throughput labs. Instead of smoothing over imperfections, we track the issues technicians report and target these with stricter in-process controls.

    Differences in Hand-Feel and Handling

    Manufacturing doesn’t stop at molecules; it extends to how powders behave on a busy bench. Some lots from competing suppliers clump, develop static, or fail to dissolve at standard loadings, forcing users to improvise. By investing in careful drying and sieving, our Fmoc-D-2-Bromophenylalanine pours reliably and integrates seamlessly during solvent pre-swelling or direct weighing into cartridge packing machines. No need to spend extra time fixing what should be invisible at the production end.

    Insight from the Factory Floor

    Each run starts with validated starting materials, and we don’t cut corners during the bromination or Fmoc-protection steps. Handling brominated aromatics at scale means carefully monitoring reaction temperatures, solvent volumes, and quenching rates. Early on, we found that not all sources of bromine and phenylalanine give equal reproducibility. We source each precursor after hands-on testing in our own systems, which keeps batch variability low. After reaction and workup, we rely on recrystallization and chromatography fine-tuned to get rid of trace side-products. When you’ve made thousands of kilograms for research and pharma users worldwide, you come to respect how even a few tenths of a percent impurity can affect multi-step sequences—or worse, throw off expensive analytical validations downstream.

    Impact on Synthetic Strategy

    Fmoc-D-2-bromophenylalanine introduces strategic options for anyone working beyond standard sequences. The D-configuration allows the creation of mirror-image, protease-resistant, or immunologically distinct peptides demanded in vaccine and drug discovery. The para bromine doesn’t just look interesting; it serves as a handle for Suzuki or other cross-coupling strategies. Peptide scientists who switch from non-halogenated analogues soon learn the downstream modification and functionalization options multiply, but only if contamination is out of the way from the start. That’s why our entire process focuses on delivering the product with both stereochemical accuracy and electronic purity preserved.

    Supported and Informed Usage

    Trainers, method developers, and technical leads depend on honest information about product performance. Our team provides batch-specific documentation and is open with users about solvent compatibility, reaction order, and observed behavior in automated synthesizers. Over the years, peptide scale-ups that seemed simple in theory revealed surprises in the hands of scientists: foam formation when dissolving, unexpected by-products, or issues with side reactions due to trace impurities. Open discussions with users helped us revise drying, packaging, and batch testing protocols. You won’t get silent, anonymous powder showing up with us. Instead, each bottle comes labeled with clear batch data and supporting analyses—not buried in fine print, but front and center on the documentation.

    Experience Highlights and Lessons Learned from Manufacturing

    Our plant background means seeing the problems that never make it into journal papers. In the early days, we saw crystallization failures when switching between scales or when environmental humidity spiked. Rather than dismiss the issue, we invested in more rigorous humidity monitoring and redesigned some of the storage workflow. Now, even in monsoon conditions, users report no caking or false readings on microbalances.

    Another lesson came from a custom peptide synthesis client whose workflow involved aggressive solvents during on-resin modifications. They shared that powders from other suppliers foamed or barely dissolved at scale, triggering frustrating re-dissolutions. We ran laboratory explorations, pinpointed the likely trace salts and anti-caking additives as culprits, and shifted drying practices to avoid these extra agents. Our Fmoc-D-2-bromophenylalanine now dissolves clean in DMF, NMP, or DMSO at any practical loading. This feedback loop between factory and benchtop shapes our current offering.

    More than a Chemical: Commitment to the Buyer’s Workflow

    We view ourselves as partners, not just as upstream providers. From the batch operator’s perspective, something as simple as a powder’s ease of opening or shelf stability over weeks can affect hours down the line. Every redesign in the packaging or tweaks in quality testing procedures answers a real technician’s experience. Professional peptide labs often work late nights or under tight timelines. Discovering a stuck cap, a mislabeled vial, or an unexpected impurity in the middle of a run wastes more than just time—it erodes confidence. This front-line reality shapes how we approach each aspect of manufacturing, storage, and batch documentation.

    No Substitute for Integrity in Ingredient Sourcing and Inspection

    At the ingredient level, we receive bulk D-phenylalanine, Fmoc-OSu, and the brominating agent from dedicated upstream partners we’ve audited. Lot-by-lot evaluation ensures no corners get cut. We aren’t tempted by cut-rate offers or uninspected lots. Any time a test batch does not meet our standards, we scrap the material, not rework it into an acceptable batch. This builds trust with users who notice that every bottle performs as expected.

    We understand that in many academic and pharmaceutical environments, rigorous traceability is not just a nicety—it is a requirement. Our full documentation trail provides answers if questions arise about a certain lot. We mark every analysis and process adjustment in our system. Experienced chemists auditing their supply chains and quality assurance managers appreciate that nothing in the product’s background is left to chance.

    Supporting Cutting-Edge Applications with Stability and Purity

    As manufacturers, we come across a range of research settings: traditional peptide synthesis labs, high-throughput screening set-ups, or those venturing into customized, conjugated peptides for diagnostics and imaging. Fmoc-D-2-Bromophenylalanine features in all of these because it simply works. Its shelf stability holds up not just over a storage quarter, but sometimes over years if labs stretch their supplies. Careful vacuum sealing and minimal headspace prevent hydrolysis and oxidation, which could otherwise reduce peptide yields or lead to costly purification steps later on. This attention to packaging, learned from practical experience, saves user time and minimizes waste.

    Environmental and Worker Safety: Handled at Every Stage

    Working with brominated organics and Fmoc-protected amino acids means dealing with materials that, if not managed well, could represent environmental or health risks. We’ve set up containment, waste tracking, and air handling protocols in our production facilities, learned over years of making these specialty amino acids. This isn’t an afterthought. It is built into every process document. All waste materials get captured, neutralized, and disposed of under monitored conditions. Worker training includes not just compliance, but hands-on drills so that rare but real accidents are handled cleanly.

    Customers frequently ask about our own environmental footprint. The answer traces back to process design: by optimizing reactions for high conversion and minimal waste, plus targeting solvent recovery and energy conservation, we’ve reduced both overall waste load and energy draw. Feedback from both local authorities and industry peers lets us keep pushing for cleaner, safer production. That same attention to safety shows in our labeling, documentation, and advice for end users handling the product, whether manually or in automated equipment. Your research environment gains the benefit of these standards without extra effort on your part.

    Continuous Improvement and Listening to End Users

    No product stands still. Each year brings improvements sparked by feedback from PhD students, post-docs, and commercial customers running pilot plants or high-throughput synthesis facilities. Open communication lines mean that if a batch ever behaves differently, we step in and trace the issue back through every part of production and handling. This has led us to tweak drying procedures, update particle size range specifications, and streamline our own bottling process to cut down on both air and moisture content.

    Some of our longest-standing users tell us the difference between a manufacturer who tests batches only to meet specs and one who thinks about real-world usability shows up in the small failures avoided: smoother dissolutions, fewer pauses for manual troubleshooting, and, most importantly, reliable yields batch after batch. Our culture rewards this kind of meticulousness. As a manufacturer, we take pride in building up expertise not from reading specifications but from watching what goes wrong—and choosing to fix it at the root level.

    Clear Distinctions from Other Protected Amino Acids and the Value for Research

    Fmoc-D-2-Bromophenylalanine sets itself apart from its L-isomer and from other halogenated phenylalanines, as well as from standard, non-halogenated Fmoc-phenylalanine. The D-configuration impacts both the secondary structure of peptides formed and their resistance to biological degradation. Bromination adds a powerful chemical handle absent in other analogs. Experienced researchers note that differences in electronic effect and solubility compared to Fmoc-D-4-bromophenylalanine or Fmoc-D-2-chlorophenylalanine matter when synthesizing libraries for SAR or medicinal chemistry campaigns.

    Subtle distinctions—like the precise position of the bromine atom on the aromatic ring, optical configuration, and level of byproduct removal—translate into hard results in structure-activity studies or in therapeutic lead development. Our rigorous focus on configuration and situational purity means our users don’t need to revalidate every parameter for each batch, but instead build cumulative experience and results.

    Enabling New Applications and Directions in Peptide Chemistry

    The landscape for peptide-based research continues to evolve. We see more interest in constrained peptides, bioconjugates with fluorescent or therapeutic labels, and applications in bio-orthogonal chemistry. Fmoc-D-2-Bromophenylalanine figures in these workflows as a flexible junction for further functionalization. As manufacturer, we share in the satisfaction when our products wind up powering innovations in drug development, diagnostics, or basic protein research. Stories shared back from our user base routinely feature peptides that would never have left the design phase without reliable access to specialty building blocks.

    Our own R&D investment aims to anticipate shifts in demand, like new methods for “click” functionalization or advances in automated solid-phase synthesis. Engineers in our teams routinely test emerging synthesis protocols using our own materials to ensure that every development on the research side can translate smoothly into pilot or production-scale operations. The end result: users can innovate with confidence, without losing days on batch-specific troubleshooting or secondary purification steps.

    Supporting Evidence and Transparent Manufacturing Practices

    Trust comes from transparency. We open our doors to academic and industry partners for audits, run documentation exchanges, and participate in technical forums to keep both our process and standards visible to the research community. Every lot ships with detailed purity data, optical rotation, and analytical spectrum. Users who require even more information—such as residual solvent profiles or trace elemental analysis—can obtain this directly without delay because we keep these records live on site. This open-book approach ensures our role in the supply chain involves both technical and ethical accountability.

    Why the Manufacturer’s Approach Matters

    From the first gram to every repeated kilogram scale-up, the difference lies in intent and action. We do not view Fmoc-D-2-Bromophenylalanine as a mere commodity molecule. It gains its value from the decades of accumulated manufacturing discipline, responsive adjustments, and hands-on technical exchanges with users around the world. Chemists who rely on our product have come to expect straight answers about challenges, readiness to troubleshoot if something goes awry, and above all, a product that delivers on its promise with every order. For us, nothing replaces years of direct manufacturing feedback and the improvements built upon that foundation.